Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianping Guo

Showing results (391-400 of 409) with videos related to

Pageof 41
Sort By:
Journal of Hepatology|March 20, 2024
FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinomaLixia Xu, Ying Zhang, Zhilong Lin, et al.
Nature Chemical Biology|September 12, 2017
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Jessica Riceberg, Teresa Soucy, et al.
Nature Genetics|January 31, 2017
A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseasesJian Zhao, Jianyang Ma, Yun Deng, et al.
Nature Medicine|August 9, 2016
Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosusJing He, Xia Zhang, Yunbo Wei, et al.
Nature Communications|April 22, 2020
Scavenger receptor-A is a biomarker and effector of rheumatoid arthritis: A large-scale multicenter studyFanlei Hu, Xiang Jiang, Chunqing Guo, et al.
Annals of the Rheumatic Diseases|April 3, 2019
Sequencing of the MHC region defines <i>HLA-DQA1</i> as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese populationJianping Guo, Tao Zhang, Hongzhi Cao, et al.
Nature Communications|March 13, 2019
Author Correction: Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
Nature Communications|December 22, 2018
Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
Clinical Rheumatology|November 30, 2018
Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled studyYuan An, Yunshan Zhou, Liqi Bi, et al.
Nature Medicine|August 15, 2017
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4Xiangpeng Dai, Wenjian Gan, Xiaoning Li, et al.
Pageof 41

Showing results (391-400 of 409) with videos related to

Sort By:
Pageof 41
Journal of Hepatology|March 20, 2024
FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinomaLixia Xu, Ying Zhang, Zhilong Lin, et al.
Nature Chemical Biology|September 12, 2017
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Jessica Riceberg, Teresa Soucy, et al.
Nature Genetics|January 31, 2017
A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseasesJian Zhao, Jianyang Ma, Yun Deng, et al.
Nature Medicine|August 9, 2016
Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosusJing He, Xia Zhang, Yunbo Wei, et al.
Nature Communications|April 22, 2020
Scavenger receptor-A is a biomarker and effector of rheumatoid arthritis: A large-scale multicenter studyFanlei Hu, Xiang Jiang, Chunqing Guo, et al.
Annals of the Rheumatic Diseases|April 3, 2019
Sequencing of the MHC region defines <i>HLA-DQA1</i> as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese populationJianping Guo, Tao Zhang, Hongzhi Cao, et al.
Nature Communications|March 13, 2019
Author Correction: Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
Nature Communications|December 22, 2018
Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
Clinical Rheumatology|November 30, 2018
Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled studyYuan An, Yunshan Zhou, Liqi Bi, et al.
Nature Medicine|August 15, 2017
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4Xiangpeng Dai, Wenjian Gan, Xiaoning Li, et al.
Pageof 41